Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 733-744 of 4,306
Drug study icon
Recruitment unclearEUCTR 2013-005399-16

Randomized, flexible-dose, open-label comparison to investigate the effectivenes of second generation antipsychotics in first episode psychosis patients.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Spain
Sponsor
Dr. Benedicto Crespo. Servicio Psiquiatría. Hospital Universitario Marqués de Valdecilla/IDIVAL
Condition
Schizophrenia
Drug study icon
CompletedNCT00357006

A Definitive Estrogen Patch Study (ADEPT)

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 18 Years to 50 Years
Countries
Australia
Sponsor
The Alfred
Condition
Schizophrenia, Bipolarity
Other study type icon
CompletedNCT01786369

Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01855074

Risperidone Long-Acting Microspheres for schizophrenia

This study is completed. It is testing Risperidone Long-Acting Microspheres for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Janssen-Cilag Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT00206570

Clinical Estradiol study in Women With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02360813

Cognitive Remediation Therapy Within a Secure Forensic Setting

This summary needs review. Please check the official study record and contact the research team for details.

In Dublin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Ireland
Sponsor
Central Mental Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04902066

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

This summary needs review. Please check the official study record and contact the research team for details.

In Copenhagen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.